PainReform Ltd. Cash and Cash Equivalents 2011-2026 | PRFX

Annual Cash and Cash Equivalents PainReform Ltd.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	15.7 M	947 K	46 K	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
15.7 M	46 K	5.56 M

Quarterly Cash and Cash Equivalents PainReform Ltd.

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	16.5 M	-	17.8 M	-	15.7 M	-	544 K	-	941 K	-	94 K	-	46 K	-	-	-	193 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
17.8 M	46 K	6.48 M

Cash and Cash Equivalents of other stocks in the Biotechnology industry

Issuer	Cash and Cash Equivalents	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	158 M	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	61.6 M	-	1052.0 %	$ 415 M	USA
Verastem VSTM	205 M	$ 5.04	-4.73 %	$ 349 M	USA
Voyager Therapeutics VYGR	65.3 M	$ 3.96	-4.12 %	$ 232 M	USA
VistaGen Therapeutics VTGN	67.1 M	$ 0.57	-5.87 %	$ 17.6 M	USA
Aeterna Zentaris AEZS	16.4 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	3.06 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	85.7 M	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	4.08 M	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	122 M	-	0.23 %	$ 488 M	USA
Akero Therapeutics AKRO	340 M	-	-	$ 3.67 B	USA
I-Mab IMAB	4.76 B	-	-	$ 866 M	China
Genfit SA GNFT	81.8 M	-	2.54 %	$ 160 B	France
Albireo Pharma ALBO	248 M	-	-0.23 %	$ 916 M	USA
Biophytis SA BPTS	5.57 M	-	-13.47 %	$ 169 M	France
Aileron Therapeutics ALRN	3.22 M	-	10.36 %	$ 9.8 M	USA
Aptinyx APTX	56.2 M	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	1.67 M	-	-18.52 %	$ 27.3 M	Britain
Arena Pharmaceuticals ARNA	220 M	-	-6.81 %	$ 3.04 B	USA
Applied Genetic Technologies Corporation AGTC	46.4 M	-	-	$ 26.5 M	USA
Avenue Therapeutics ATXI	2.59 M	-	-52.27 %	$ 4.45 M	USA
Ayala Pharmaceuticals AYLA	2.41 M	-	-	$ 7.46 M	Israel
Atreca BCEL	30.8 M	-	-11.76 %	$ 5.79 M	USA
Acorda Therapeutics ACOR	30 M	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	222 M	-	-	$ 546 M	USA
Acasti Pharma ACST	22.1 M	-	4.01 %	$ 150 M	Canada
Avid Bioservices CDMO	38.1 M	-	-	$ 789 M	USA
Adverum Biotechnologies ADVM	60.7 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	2.33 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	4.88 M	-	-9.65 %	$ 45.9 M	USA
Adaptive Biotechnologies Corporation ADPT	70.5 M	$ 12.41	-11.1 %	$ 1.88 B	USA
Wave Life Sciences Ltd. WVE	602 M	$ 6.37	2.66 %	$ 1.07 B	Singapore
Xenetic Biosciences XBIO	7.88 M	$ 2.72	-2.86 %	$ 4.63 M	USA
XBiotech XBIT	126 M	$ 2.27	-1.73 %	$ 69.2 M	USA
Xenon Pharmaceuticals XENE	143 M	$ 54.48	-1.89 %	$ 4.24 B	Canada
Xeris Pharmaceuticals XERS	111 M	$ 5.4	-3.05 %	$ 866 M	USA
X4 Pharmaceuticals XFOR	217 M	$ 4.04	-6.26 %	$ 171 M	USA
Xencor XNCR	54.1 M	$ 11.42	-7.23 %	$ 848 M	USA
XOMA Corporation XOMA	82.9 M	$ 30.17	-1.18 %	$ 364 M	USA
BeiGene, Ltd. BGNE	4.55 B	-	0.49 %	$ 251 B	Cayman-islands
22nd Century Group XXII	7.15 M	$ 2.41	-18.03 %	$ 444 K	USA
BioDelivery Sciences International BDSI	112 M	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	51.8 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	50 M	-	-	$ 3.74 B	USA
Zai Lab Limited ZLAB	680 M	$ 18.0	2.8 %	$ 19.7 B	China
Enlivex Therapeutics Ltd. ENLV	5.67 M	$ 1.05	-3.67 %	$ 21.5 M	Israel
Enochian Biosciences ENOB	92.7 K	-	-	$ 40.5 M	USA